Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Doximity, Inc.

CIK 1516513Updated Sep 27, 2026

DOCS price & chart

Provider market data

Loading TradingView…

NYSE:DOCS on TradingView ↗

TradingView · Data may be delayed

About the company

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. With new AI-powered clinical reference and search capabilities, Doximity also helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

8-K · 2026-08-06 · 0001516513-26-000038

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Recent filings

  1. 144 filing

    144 · 2026-09-15 · 0001950047-26-009466

  2. Submission of Matters to a Vote of Security Holders

    Items 5.07

    8-K · 2026-09-02 · 0001516513-26-000045

  3. 4 filing

    4 · 2026-08-31 · 0001470831-26-000857

  4. 4 filing

    4 · 2026-08-31 · 0001470831-26-000855

  5. 4 filing

    4 · 2026-08-17 · 0001470831-26-000825

Show 5 more recent filings
  1. 144 filing

    144 · 2026-08-13 · 0001950047-26-008058

  2. 144 filing

    144 · 2026-08-07 · 0001950047-26-007824

  3. 10-Q filing

    10-Q · 2026-08-06 · 0001516513-26-000040

  4. Results of Operations and Financial Condition

    Items 2.02, 9.01

    8-K · 2026-08-06 · 0001516513-26-000038

  5. 4 filing

    4 · 2026-07-24 · 0001230589-26-000004

Financials

FY 2026 · USD
Revenue644,863,000USD · FY 2026
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

Net income196,051,000USD · FY 2026
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

Operating income214,920,000USD · FY 2026
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

Diluted EPS0.98USD per share · FY 2026
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2026FY 2025FY 2024FY 2023
ASSETS
AssetsUSD1,123,687,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

1,264,309,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

1,079,374,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

1,136,888,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Property, Plant and Equipment, NetUSD18,080,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

13,656,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

12,318,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

11,279,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

GoodwillUSD84,973,000
Source

10-Q · 2026-08-06 · 0001516513-26-000040

As of 2026-06-30

67,940,000
Source

10-Q · 2025-08-07 · 0001516513-25-000093

As of 2025-06-30

67,940,000
Source

10-Q · 2025-02-06 · 0001516513-25-000012

As of 2024-12-31

67,940,000
Source

10-Q · 2024-02-08 · 0001516513-24-000009

As of 2023-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD219,178,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

209,614,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

96,785,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

158,027,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD144,783,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

128,354,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

101,332,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

107,047,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Assets, CurrentUSD944,264,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

1,088,620,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

912,941,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

975,453,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Prepaid Expense and Other Assets, CurrentUSD50,880,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

44,602,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

48,709,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

22,289,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Operating Lease, Right-of-Use AssetUSD7,140,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

8,886,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

12,332,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

13,819,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Other Assets, NoncurrentUSD1,921,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

2,121,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

1,458,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

1,654,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

LIABILITIES AND EQUITY
LiabilitiesUSD172,850,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

181,684,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

177,977,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

170,772,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD0
Source

10-Q · 2026-08-06 · 0001516513-26-000040

As of 2026-06-30

0
Source

10-Q · 2026-02-05 · 0001516513-26-000006

As of 2025-12-31

0
Source

10-Q · 2025-02-06 · 0001516513-25-000012

As of 2024-12-31

0
Source

10-Q · 2024-02-08 · 0001516513-24-000009

As of 2023-12-31

Common Stock, Value, IssuedUSD183,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

189,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

187,000
Source

10-Q · 2024-11-07 · 0001516513-24-000102

As of 2024-09-30

194,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Additional Paid in CapitalUSD1,001,688,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

894,225,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

823,885,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

762,150,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Retained Earnings (Accumulated Deficit)USD-51,062,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

186,888,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

79,989,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

217,855,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD28,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

1,323,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

-2,664,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

-14,083,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Stockholders' Equity Attributable to ParentUSD950,837,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

1,082,625,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

901,397,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

966,116,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Liabilities and EquityUSD1,123,687,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

1,264,309,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

1,079,374,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

1,136,888,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Current liabilities:
Liabilities, CurrentUSD154,973,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

156,257,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

147,250,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

139,507,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Operating Lease, Liability, CurrentUSD2,110,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

2,211,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

2,149,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

1,752,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Accounts Payable, CurrentUSD4,009,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

1,356,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

2,253,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

1,272,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Operating Lease, Liability, NoncurrentUSD8,075,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

10,185,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

12,397,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

13,885,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Other Liabilities, NoncurrentUSD9,402,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

9,383,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

7,224,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

1,240,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Additional Financial Items
Accrued Liabilities, CurrentUSD—38,405,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

43,703,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

31,245,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD———809,247,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2026FY 2025FY 2024FY 2023
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD14,383,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

10,659,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

10,265,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

10,283,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Share-based Payment Arrangement, Noncash ExpenseUSD121,627,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

72,386,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

51,076,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

47,834,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD16,879,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

27,206,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

-3,993,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

26,242,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Deferred Income Tax Expense (Benefit)USD32,138,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

-11,592,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

-8,593,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

13,226,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Net Cash Provided by (Used in) Operating ActivitiesUSD326,458,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

273,265,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

184,096,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

179,602,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Cash flows from investing activities:
Payments to Acquire Businesses, Net of Cash AcquiredUSD26,528,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

0
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

0
Source

10-Q · 2026-02-05 · 0001516513-26-000006

2024-04-01 to 2024-12-31

53,500,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Net Cash Provided by (Used in) Investing ActivitiesUSD147,170,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

-29,298,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

31,186,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

-59,923,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Payments for (Proceeds from) Other Investing ActivitiesUSD——0
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

0
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

Payments to Acquire Property, Plant, and EquipmentUSD0
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

0
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

147,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

1,701,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Cash flows from financing activities:
Payment, Tax Withholding, Share-based Payment ArrangementUSD40,839,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

27,185,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

6,756,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

3,822,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Payments for Repurchase of Common StockUSD431,652,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

120,293,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

280,716,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

85,324,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Net Cash Provided by (Used in) Financing ActivitiesUSD-464,064,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

-131,138,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

-276,524,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

-74,461,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD9,564,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

112,829,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

-61,242,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

45,218,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD219,178,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

As of 2026-03-31

209,614,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

As of 2025-03-31

96,785,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

As of 2024-03-31

158,027,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

Supplemental disclosure of cash flow information:
Income Taxes Paid, NetUSD21,814,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

———
Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD121,627,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

72,386,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

51,076,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

47,834,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Amortization of Intangible AssetsUSD6,500,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

4,300,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

4,600,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

4,800,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Capitalized Computer Software, AmortizationUSD7,400,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

5,800,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

5,000,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

4,800,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Cash, Cash Equivalents, and Short-term InvestmentsUSD———809,247,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

As of 2023-03-31

DepreciationUSD7,900,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

6,400,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

5,700,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

5,500,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Gain (Loss) on InvestmentsUSD188,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

169,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

-402,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

-1,093,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Gain (Loss) on Disposition of BusinessUSD———0
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

General and Administrative ExpenseUSD65,267,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

45,670,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

37,827,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

36,745,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

GoodwillUSD84,973,000
Source

10-Q · 2026-08-06 · 0001516513-26-000040

As of 2026-06-30

67,940,000
Source

10-Q · 2025-08-07 · 0001516513-25-000093

As of 2025-06-30

67,940,000
Source

10-Q · 2025-02-06 · 0001516513-25-000012

As of 2024-12-31

67,940,000
Source

10-Q · 2024-02-08 · 0001516513-24-000009

As of 2023-12-31

Goodwill, Impairment LossUSD0
Source

10-Q · 2026-08-06 · 0001516513-26-000040

2026-04-01 to 2026-06-30

0
Source

10-Q · 2026-02-05 · 0001516513-26-000006

2025-04-01 to 2025-12-31

0
Source

10-Q · 2025-02-06 · 0001516513-25-000012

2024-04-01 to 2024-12-31

0
Source

10-Q · 2024-02-08 · 0001516513-24-000009

2023-04-01 to 2023-12-31

Impairment of Intangible Assets (Excluding Goodwill)USD0
Source

10-Q · 2026-08-06 · 0001516513-26-000040

2026-04-01 to 2026-06-30

———
Income Tax Expense (Benefit)USD53,954,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

40,389,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

37,620,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

20,338,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Net Income (Loss) Attributable to ParentUSD196,051,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

223,185,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

147,582,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

112,818,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——147,582,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

112,818,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Nonoperating Income (Expense)USD35,085,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

———
Operating ExpensesUSD359,617,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

286,725,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

260,875,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

240,454,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Other Nonoperating Income (Expense)USD-806,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

-247,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

62,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

8,048,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD561,434,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

635,401,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

435,179,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

83,139,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Restructuring Costs and Asset Impairment ChargesUSD0
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

———

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2026FY 2025FY 2024FY 2023
Total RevenueUSD644,863,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

570,399,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

475,422,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

419,052,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Cost of Goods and Services Sold————
Operating Income (Loss)USD214,920,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

227,800,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

163,878,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

125,108,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Other Nonoperating Income (Expense)USD-806,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

-247,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

62,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

8,048,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD250,005,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

263,574,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

185,202,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

133,156,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Income Tax Expense (Benefit)USD53,954,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

40,389,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

37,620,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

20,338,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Net Income (Loss) Attributable to ParentUSD196,051,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

223,185,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

147,582,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

112,818,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Earnings Per Share, BasicUSD per share1.05
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

1.19
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

0.78
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

0.58
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Earnings Per Share, DilutedUSD per share0.98
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

1.11
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

0.72
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

0.53
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Weighted Average Number of Shares Outstanding, Basicshares187,014,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

186,841,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

190,172,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

193,176,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Weighted Average Number of Shares Outstanding, Dilutedshares199,048,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

201,208,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

205,734,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

213,425,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Additional Financial Items
Amortization of Intangible AssetsUSD6,500,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

4,300,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

4,600,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

4,800,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Capitalized Computer Software, AmortizationUSD7,400,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

5,800,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

5,000,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

4,800,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Current Income Tax Expense (Benefit)USD21,816,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

———
Gain (Loss) on InvestmentsUSD188,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

169,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

-402,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

-1,093,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

General and Administrative ExpenseUSD65,267,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

45,670,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

37,827,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

36,745,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Goodwill, Impairment LossUSD0
Source

10-Q · 2026-08-06 · 0001516513-26-000040

2026-04-01 to 2026-06-30

0
Source

10-Q · 2026-02-05 · 0001516513-26-000006

2025-04-01 to 2025-12-31

0
Source

10-Q · 2025-02-06 · 0001516513-25-000012

2024-04-01 to 2024-12-31

0
Source

10-Q · 2024-02-08 · 0001516513-24-000009

2023-04-01 to 2023-12-31

Gross ProfitUSD574,537,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

514,525,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

424,753,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

365,562,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Interest Income (Expense), Nonoperating, NetUSD35,703,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

35,852,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

21,664,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

9,287,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——147,582,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

112,818,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Nonoperating Income (Expense)USD35,085,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

———
Operating ExpensesUSD359,617,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

286,725,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

260,875,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

240,454,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Research and Development ExpenseUSD130,702,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

93,038,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

81,983,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

80,186,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Selling and Marketing ExpenseUSD163,648,000
Source

10-K · 2026-05-19 · 0001516513-26-000025

2025-04-01 to 2026-03-31

145,713,000
Source

10-K · 2025-05-20 · 0001516513-25-000056

2024-04-01 to 2025-03-31

133,129,000
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

123,523,000
Source

10-K · 2023-05-26 · 0001516513-23-000036

2022-04-01 to 2023-03-31

Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD——0
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

0
Source

10-K · 2024-05-23 · 0001516513-24-000035

2023-04-01 to 2024-03-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

doximity-2026630xex991.htm · 8-K · 2026-08-06

EX-99.1 2 doximity-2026630xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2027 First Quarter Financial Results Total revenues of $156.6 million, up 7% year-over-year Net income of $24.3 million, margin of 16% Adjusted EBITDA of $74.8 million, margin of 48% SAN FRANCISCO, Calif., August 6, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 first quarter ended June 30, 2026. “We'…

8-K · 2026-08-06 · 0001516513-26-000038

Read attachment ↗
doximity-2026331xex991.htm · 8-K · 2026-05-13

EX-99.1 2 doximity-2026331xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results Fiscal year 2026 total revenues of $644.9 million, up 13% year-over-year Fiscal year 2026 operating cash flows of $326.5 million, up 19% year-over-year Fiscal year 2026 free cash flow of $317.5 million, up 19% year-over-year SAN FRANCISCO, Calif., May 13, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professiona…

8-K · 2026-05-13 · 0001516513-26-000017

Read attachment ↗
doximity-20251231xex991.htm · 8-K · 2026-02-05

EX-99.1 2 doximity-20251231xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2026 Third Quarter Financial Results Total revenues of $185.1 million, up 10% year-over-year Net income of $61.6 million, margin of 33% Adjusted EBITDA of $111.4 million, margin of 60% SAN FRANCISCO, Calif., February 5, 2026 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 20…

8-K · 2026-02-05 · 0001516513-26-000004

Read attachment ↗
doximity-2025930xex991.htm · 8-K · 2025-11-06

EX-99.1 2 doximity-2025930xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2026 Second Quarter Financial Results Total revenues of $168.5 million, up 23% year-over-year Operating cash flow of $93.9 million, up 37% year-over-year Free cash flow of $91.6 million, up 37% year-over-year SAN FRANCISCO, Calif., November 6, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quart…

8-K · 2025-11-06 · 0001516513-25-000110

Read attachment ↗
doximity-2025630xex991.htm · 8-K · 2025-08-07

EX-99.1 2 doximity-2025630xex991.htm EX-99.1 Document Exhibit 99.1 Doximity Announces Fiscal 2026 First Quarter Financial Results Total revenues of $145.9 million, up 15% year-over-year Operating cash flow of $62.1 million, up 51% year-over-year Free cash flow of $60.1 million, up 52% year-over-year SAN FRANCISCO, Calif., August 7, 2025 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter e…

8-K · 2025-08-07 · 0001516513-25-000092

Read attachment ↗
doximity-2025613xex991.htm · 8-K · 2025-06-13

EX-99.1 2 doximity-2025613xex991.htm EX-99.1 Document Thank you, Nate! After 15 wonderful years, our co-founder, partner, and pyramid topper (!), Dr. Nate Gross is moving on. He’ll remain an advisor here at Doximity, but not in a day-to-day role. We will miss him. I first met Nate when he was co-founding Rock Health back in 2009. I recall being so impressed that he’d re-engineered his hospital’s pager software to run on his iPhone. He was then, and remains now, a human encyclopedia of dig…

8-K · 2025-06-13 · 0001516513-25-000065

Read attachment ↗